1. Association AP. DSM-IV-TR: Diagnostic and statistical manual of mental disorders, text revision. Washington, DC: American Psychiatric Association; 2000. 78-85 p.
2. Saki K, Bahmani M and Rafieian-Kopaei M. The effect of most important medicinal plants ontwo importnt psychiatric disorders (anxiety and depression)-a review. Asian Pac J Trop Med. 2014; 7: S34-S42. [
DOI:10.1016/S1995-7645(14)60201-7]
3. Lehtinen V and Joukamaa M. Epidemiology of depression: prevalence, risk factors and treatment situation. Acta Psychiatr Scand. 1994; 89(s377): 7-10. [
DOI:10.1111/j.1600-0447.1994.tb05794.x]
4. Bibring E. The mechanism of depression. 1953.
5. Beutler LE, Clarkin JF and Bongar B. Guidelines for the systematic treatment of the depressed patient. UK: Oxford University Press; 2000. [
DOI:10.1093/acprof:oso/9780195105308.001.0001]
6. Samuelsson G. Drugs of natural origin. Swedish Pharmaceutical Society. Stockholm, Sweden: Swedish Pharmaceutical Press; 1999.
7. Luo H, Cai C, Zhang J and Mo L. Study on the chemical components of Alpinia officinarum. J Chinese Med Mat. 1998; 21(7): 349-351.
8. Wei L and Linghuo J. Chemical Constituents and Pharmacological Activities of Alpinia officinarum Hance [J]. China Pharma. 2006; 3: 014.
9. Mirzaei K, Hossein-nezhad A, Aslani S, Emamgholipour S, Karimi M and Keshavarz S. Energy expenditure regulation via macrophage migration inhibitory factor in obesity and in vitro anti-macrophage migration inhibitory factor effect of Alpinia officinarum hance extraction. Endocr Pract. 2011; 18(1): 39-48. [
DOI:10.4158/EP11116.OR]
10. Kirtikar KR. Indian Medicinal Plants Vol-4. Dehradun: Bishen Singh Mahendra Pal Singh; 1918.
11. Köse LP, Gülçin İ, Gören AC, Namiesnik J, Martinez-Ayala AL and Gorinstein S. LC-MS/MS analysis, antioxidant and anticholinergic properties of galanga (Alpinia officinarum Hance) rhizomes. Ind Crops Prod. 2015; 74: 712-721. [
DOI:10.1016/j.indcrop.2015.05.034]
12. Srividya A, Dhanabal S, Misra V and Suja G. Antioxidant and antimicrobialactivity of Alpinia officinarum. Indian J Pharm Sci. 2010; 72(1): 145. [
DOI:10.4103/0250-474X.62233]
13. Yadav PN, Liu Z and Rafi MM. A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-κB. J Pharmacol Exper Therap. 2003; 305(3): 925-931. [
DOI:10.1124/jpet.103.049171]
14. Yasukawa K, Sun Y, Kitanaka S, Tomizawa N, Miura M and Motohashi S. Inhibitory effect of the rhizomes of Alpinia officinarum on TPA-induced inflammation and tumorpromotion in two-stage carcinogenesis in mouse skin. J. Nat. Med. 2008; 62(3): 374. [
DOI:10.1007/s11418-008-0243-2]
15. Kaushik P, Kaushik D, Yadav J and Pahwa P. Protective effect of Alpinia galanga in STZ induced diabetic nephropathy. Pak. J. Biol. Sci. 2013; 16(16): 804-811. [
DOI:10.3923/pjbs.2013.804.811]
16. Lee J, Kim KA, Jeong S, Lee S, Park HJ, Kim NJ and et al. Anti-inflammatory, anti-nociceptive, and anti-psychiatric effects by the rhizomes of Alpinia officinarum on complete Freund's adjuvant-induced arthritis in rats. J. Ethnopharmacol. 2009; 126(2): 258-264. [
DOI:10.1016/j.jep.2009.08.033]
17. Huang X, TangG, Liao Y, Zhuang X, Dong X, Liu H and et al. 7-(4-Hydroxyphenyl)-1-phenyl-4E-hepten-3-one, a Diarylheptanoid from Alpinia officinarum, Protects Neurons against Amyloid-β Induced Toxicity. Biol Pharm Bull. 2016; 39(12): 1961-7. [
DOI:10.1248/bpb.b16-00411]
18. Council NR. Guide for the care and use of laboratory animals: National Academies Press; 2010.
19. Kumar B, Kuhad A and Chopra K. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. Psychopharmacol. 2010; 214(4): 819-828. [
DOI:10.1007/s00213-010-2094-2]
20. Rabiei Z, Gholami M and Rafieian-Kopaei M. Antidepressant effects of Mentha pulegium in mice. Bangladesh J. Pharmacol. 2016; 11(3): 711-715. [
DOI:10.3329/bjp.v11i3.27318]
21. Schaalan MF and Nassar NN. Effects of octreotide in chronically mild stressed rats: possible role of immune and oxidative stress pathways. Neurochem Res. 2011; 36(10): 1717. [
DOI:10.1007/s11064-011-0486-2]
22. Eren İ, Nazıroğlu M and Demirdaş A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neuroch Res. 2007; 32(7): 1188-1195. [
DOI:10.1007/s11064-007-9289-x]
23. Lucca G, Comim CM, Valvassori SS, Réus GZ, Vuolo F, Petronilho F and et al. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int. 2009; 54(5-6): 358-362. [
DOI:10.1016/j.neuint.2009.01.001]
24. Grundmann O, Lv Y, Kelber O and Butterweck V. Mechanism of St. John's wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system. Neuropharmacol. 2010; 58(4-5): 767-773. [
DOI:10.1016/j.neuropharm.2009.12.014]
25. Lei Y, Chen J, Zhang W, Fu W, Wu G, Wei H and et al. In vivo investigation on the potential of galangin, kaempferol and myricetin for protection of D-galactose-induced cognitive impairment. Food Chem. 2012; 135(4): 2702-2707. [
DOI:10.1016/j.foodchem.2012.07.043]
26. You Z, Luo C, Zhang W, Chen Y, He J, Zhao Q and et al. Pro-and anti-inflammatorycytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression. Behav Brain Res. 2011; 225(1): 135-141. [
DOI:10.1016/j.bbr.2011.07.006]
27. Müller N, Schwarz M, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B and et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatr. 2006; 11(7): 680. [
DOI:10.1038/sj.mp.4001805]
28. Tao L, Wang Z-T, Zhu E-Y, Lu Y-H and Wei D-Z. HPLC analysis of bioactive flavonoids from the rhizome of Alpinia officinarum. S. Afr. J. Botan. 2006; 72(1): 163-166. [
DOI:10.1016/j.sajb.2005.06.007]